David L. Wachter

3.7k total citations
59 papers, 1.8k citations indexed

About

David L. Wachter is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, David L. Wachter has authored 59 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cancer Research, 20 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in David L. Wachter's work include Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (8 papers) and HER2/EGFR in Cancer Research (8 papers). David L. Wachter is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), Breast Lesions and Carcinomas (8 papers) and HER2/EGFR in Cancer Research (8 papers). David L. Wachter collaborates with scholars based in Germany, United States and Switzerland. David L. Wachter's co-authors include Matthias W. Beckmann, Arndt Hartmann, Peter A. Fasching, Abbas Agaimy, Johanna Strehl, Matthias Ruebner, Claudia Rauh, Alexander Hein, Michael P. Lux and Katharina Heusinger and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

David L. Wachter

59 papers receiving 1.7k citations

Peers

Countries citing papers authored by David L. Wachter

Since Specialization

Citations

This map shows the geographic impact of David L. Wachter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Wachter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Wachter more than expected).

Fields of papers citing papers by David L. Wachter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Wachter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Wachter. The network helps show where David L. Wachter may publish in the future.

Co-authorship network of co-authors of David L. Wachter

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Wachter. A scholar is included among the top collaborators of David L. Wachter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Wachter. David L. Wachter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis 2023 ·Diagnostics ·(unknown), Peter A. Fasching, Lothar Häberle, Julia Meyer, Michael Schneider, David L. Wachter, Matthias Ruebner, (unknown), Matthias W. Beckmann, Arndt Hartmann, Ramona Erber, Paul Gaß	7
2	Characterization of Molecular Subtypes of Paget Disease of the Breast Using Immunohistochemistry and In Situ Hybridization 2018 ·Archives of Pathology & Laboratory Medicine ·David L. Wachter, (unknown), Peter A. Fasching, Matthias W. Beckmann, Carolin C. Hack, Marc‐Oliver Riener, Arndt Hartmann, Johanna Strehl	14
3	The importance of pancreatic inflammation in endosonographic diagnostics of solid pancreatic masses 2018 ·Medical Ultrasonography ·Francesco Vitali, Deike Strobel, Luca Frulloni, Marc Heinrich, Lukáš Pfeifer, Ruediger S. Goertz, Gheorghe Hundorfean, David L. Wachter, (unknown), T. Bernatik, Markus F. Neurath, Dane Wildner	6
4	Expression and Regulation of Retinoic Acid Receptor Responders in the Human Placenta 2017 ·Reproductive Sciences ·Hanna Huebner, Andrea Hartner, Wolfgang Rascher, Reiner Strick, Sven Kehl, Felix Heindl, David L. Wachter, Matthias W. Beckmann, Fabian B. Fahlbusch, Matthias Ruebner	14
5	DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer 2016 ·Nature Communications ·Andrew E. Teschendorff, Yang Gao, Allison Jones, Matthias Ruebner, Matthias W. Beckmann, David L. Wachter, Peter A. Fasching, Martin Widschwendter	157
6	Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study 2015 ·BMC Cancer ·Stefanie Burghaus, Lothar Häberle, Michael Schrauder, Katharina Heusinger, Falk C. Thiel, Alexander Hein, David L. Wachter, Johanna Strehl, Arndt Hartmann, Arif B. Ekici, Stefan P. Renner, Matthias W. Beckmann, Peter A. Fasching	25
7	Fine needle aspiration cytology of lymph nodes in breast cancer follow-up is a feasible alternative to watchful waiting and to histology 2015 ·BMC Women s Health ·Matthias Hammon, Peter Dankerl, Rolf Janka, David L. Wachter, Arndt Hartmann, Rüdiger Schulz‐Wendtland, Michael Uder, Evelyn Wenkel	5
8	Sebaziöses Mammakarzinom 2014 ·Der Pathologe ·David L. Wachter, Claudia Rauh, Evelyn Wenkel, Peter A. Fasching, Matthias W. Beckmann, Arndt Hartmann	3
9	SMARCB1(INI1)-deficient Sinonasal Basaloid Carcinoma 2014 ·The American Journal of Surgical Pathology ·Abbas Agaimy, (unknown), Michael Lell, Sabine Semrau, Wojciech Dudek, David L. Wachter, Antje Knöll, Heinrich Iro, Florian Haller, Arndt Hartmann	122
10	The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration 2013 ·Placenta ·Fabian B. Fahlbusch, Matthias Ruebner, Hanna Huebner, (unknown), (unknown), (unknown), (unknown), Carlos Menendez‐Castro, David L. Wachter, Andrea Hartner, Wolfgang Rascher	16
11	A Functional Yeast Survival Screen of Tumor-Derived cDNA Libraries Designed to Identify Anti-Apoptotic Mammalian Oncogenes 2013 ·PLoS ONE ·Moritz F. Eissmann, Bettina Schwamb, (unknown), Julia Moser, (unknown), Ulrike Köhl, Ralf J. Rieker, David L. Wachter, Abbas Agaimy, Esther Herpel, Peter Baumgarten, Michel Mittelbronn, Stefanie Rakel, Donat Kögel, Stefanie Böhm, Tony Gutschner, Sven Diederichs, Martin Zörnig	17
12	Association of mammographic density with the proliferation marker Ki-67 in a cohort of patients with invasive breast cancer 2012 ·Breast Cancer Research and Treatment ·Katharina Heusinger, Sebastian M. Jud, Lothar Häberle, Carolin C. Hack, Peter A. Fasching, M. Meier-Meitinger, Michael P. Lux, Carsten Hagenbeck, Christian R. Loehberg, Thomas Wittenberg, Claudia Rauh, Florian Wagner, Michael Uder, Arndt Hartmann, Rüdiger Schulz‐Wendtland, Matthias W. Beckmann, David L. Wachter	27
13	Tissue Remodeling and Nonendometrium-Like Menstrual Cycling Are Hallmarks of Peritoneal Endometriosis Lesions 2012 ·Reproductive Sciences ·Florian Sohler, Anette Sommer, David L. Wachter, Abbas Agaimy, Oliver M. Fischer, Stefan P. Renner, Stefanie Burghaus, Peter A. Fasching, Matthias W. Beckmann, Ulrike Fuhrmann, Reiner Strick, Pamela L. Strissel	19
14	Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patients 2012 ·Archives of Gynecology and Obstetrics ·David L. Wachter, Peter A. Fasching, Lothar Haeberle, R. Schulz-Wendtland, Arno Dimmler, (unknown), Stefan P. Renner, Michael P. Lux, Matthias W. Beckmann, Arndt Hartmann, Claudia Rauh, Michael Schrauder	12
15	Hormone replacement therapy and prognosis in ovarian cancer patients 2012 ·European Journal of Cancer Prevention ·Alexander Hein, Falk C. Thiel, Christian Bayer, Peter A. Fasching, Lothar Häberle, Michael P. Lux, Stefan P. Renner, Sebastian M. Jud, Michael Schrauder, Andreas Müller, David L. Wachter, Johanna Strehl, Arndt Hartmann, Matthias W. Beckmann, Claudia Rauh	20
16	Paratesticular cystadenomas with ovarian stroma, metaplastic serous müllerian epithelium, and male adnexal tumor of probable wolffian origin 2012 ·Annals of Diagnostic Pathology ·Michal Michal, Dmitry V. Kazakov, Denisa Kacerovská, Naoto Kuroda, Eva Lovrić, David L. Wachter, Abbas Agaimy, Ondřej Hes	17
17	Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment 2011 ·BMC Cancer ·Peter A. Fasching, Katharina Heusinger, Lothar Haeberle, (unknown), Alexander Hein, Christian Bayer, Claudia Rauh, R. Schulz-Wendtland, Mayada R. Bani, Michael Schrauder, Laura Kahmann, Michael P. Lux, Johanna Strehl, Arndt Hartmann, Arno Dimmler, Matthias W. Beckmann, David L. Wachter	241
18	Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response 2011 ·European Radiology ·(unknown), (unknown), Martin Hupfer, Tristan Nowak, Laura Lotz, Inge Hoffmann, David L. Wachter, Ralf Dittrich, Matthias W. Beckmann, Gregor Jošt, Hubertus Pietsch, Willi A. Kalender	14
19	Insulin‐like growth factor II mRNA‐binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value 2011 ·Histopathology ·David L. Wachter, Glen Kristiansen, Christopher Soll, Claus Hellerbrand, Kai Breuhahn, Florian Fritzsche, Abbas Agaimy, Arndt Hartmann, Marc‐Oliver Riener	28
20	Assessment of breast cancer tumour size using six different methods 2010 ·European Radiology ·M. Meier-Meitinger, Lothar Häberle, Peter A. Fasching, Mayada R. Bani, Katharina Heusinger, David L. Wachter, Matthias W. Beckmann, Michael Uder, Rüdiger Schulz‐Wendtland, Boris Adamietz	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact